Kv3.1 and Kv3.4, Are Involved in Cancer Cell Migration and InvasionMin Seok Song, Sohee Lee|International Journal of Molecular Sciences|2018Cited by 35
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Feng Wang, Zhiquan Luo et al.|European Journal of Cancer|2024Cited by 18